Safety and immunogenicity evaluation of an intranasal recombinant flagellin subunit Campylobacter vaccine (rFla-MBP) [Campylobacter jejuni vaccine] in volunteers
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Campylobacter jejuni vaccine (Primary)
- Indications Campylobacter infections
- Focus Adverse reactions; Pharmacodynamics
- 26 Sep 2017 Biomarkers information updated
- 12 Jan 2010 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.